Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana® Press when Injected Every Four Months (FHI 360 2017-2020)
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'This study evaluated the effectiveness, PK, safety, and acceptability of Sayana® Press when injected every 4 months for 12 months (3 treatment cycles), rather than every 3 months per current prescribing information. A total of 750 healthy, sexually active women aged 18 to 35 years with regular menstrual cycles and at risk of pregnancy were enrolled at 3 sites in the Dominican Republic, Brazil, and Chile. One cohort of N=630 women was randomized 1:1 to receive injections of Sayana® Press in the abdomen or upper thigh, and a second PK cohort of N=120 women who, in addition to pregnancy testing, agreed to blood draws for MPA testing at 6 time points during their study participation, was randomized 1:1:1 to receive injections in the abdomen, upper thigh, or back of the upper arm. The N=710 women receiving injections in the abdomen or thigh,' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Contraception","Injectables","Pharmacokinetics","Pregnancy","Sayana Press"]} <|eot_id|>
 Here is the Description of a dataset. Description:'This study evaluated the effectiveness, PK, safety, and acceptability of Sayana® Press when injected every 4 months for 12 months (3 treatment cycles), rather than every 3 months per current prescribing information. A total of 750 healthy, sexually active women aged 18 to 35 years with regular menstrual cycles and at risk of pregnancy were enrolled at 3 sites in the Dominican Republic, Brazil, and Chile. One cohort of N=630 women was randomized 1:1 to receive injections of Sayana® Press in the abdomen or upper thigh, and a second PK cohort of N=120 women who, in addition to pregnancy testing, agreed to blood draws for MPA testing at 6 time points during their study participation, was randomized 1:1:1 to receive injections in the abdomen, upper thigh, or back of the upper arm. The N=710 women receiving injections in the abdomen or thigh,' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
This study evaluated the effectiveness, PK, safety, and acceptability of Sayana® Press when injected every 4 months for 12 months (3 treatment cycles), rather than every 3 months per current prescribing information. A total of 750 healthy, sexually active women aged 18 to 35 years with regular menstrual cycles and at risk of pregnancy were enrolled at 3 sites in the Dominican Republic, Brazil, and Chile. One cohort of N=630 women was randomized 1:1 to receive injections of Sayana® Press in the abdomen or upper thigh, and a second PK cohort of N=120 women who, in addition to pregnancy testing, agreed to blood draws for MPA testing at 6 time points during their study participation, was randomized 1:1:1 to receive injections in the abdomen, upper thigh, or back of the upper arm. The N=710 women receiving injections in the abdomen or thigh,
Contraception; Injectables; Pharmacokinetics; Pregnancy; Sayana Press